A5004541725- Pharmacological Effects and Toxicity Studies
- Hemoglobinopathies and Related Disorders
- Iron Metabolism and Disorders
- Reconstructive Surgery and Microvascular Techniques
- Surgical Sutures and Adhesives
Gazi University
2024
Hacettepe University
2016
Iron chelation therapy is one of the mainstays management patients with β-thalassemia (BT) major. Deferasirox an oral active iron chelating agent. Proteinuria potential renal adverse effects deferasirox, and monthly follow-up for proteinuria suggested by Food Drug Administration European Medicine Agency.We aimed to investigate necessity monitoring among BT on deferasirox. A retrospective laboratory clinic data review was performed major or intermedia who were treated deferasirox therapy. All...
Cesarean section (CS) is a widely performed operation worldwide but data about uterine closure are lacking. We aimed to evaluate scar niches and compare single-layer double-layer at 6 months following CS.